Globus Medical Inc Receivables Turnover Ratio (GMED), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Globus Medical Inc   (NYSE: GMED)
 

Globus Medical Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Globus Medical Inc 's ability to collect accounts receivable sequentially worsen to 4.7, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Globus Medical Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 78 days, from 76 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 416 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1219 to 2873.

What is Receivable Turnover Ratio?
What is Globus Medical Inc Selling?


What is Receivable Turnover Ratio?





GMED Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 13.18 % 28.28 % 21.74 % 5.28 % -0.04 %
Y / Y Revenue Change 5.94 % 27.04 % 25.73 % 22.91 % 18.37 %
Receivable Turnover Ratio (TTM) 4.7 4.78 4.81 4.77 4.58
GMED's Total Ranking # 2873 # 1219 # 1614 # 1749 # 1772
Accounts Receivable average collection period days 78 76 76 77 80
Seq. Receivable Change 0.84 % 1.1 % 9.66 % 1.23 % 14.29 %
Seq. Revenue Change 3.92 % -8.05 % 7.46 % 3.18 % 24.61 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 155
Healthcare Sector # 417
Overall Market # 2873

Receivable Turnover Ratio Statistics
High Average Low
7.01 5.56 4.15
(Dec 31 2012)   (Sep 30 2023)






Financial Statements
Globus Medical Inc 's Accounts Receivable $ 692 Millions Visit GMED's Balance sheet
Globus Medical Inc 's Sales TTM $ 3,145 Millions Visit GMED's Income Statement
Sources of GMED's Revenues Visit GMED's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GMED's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GMED's Growth Rates GMED's Roa GMED's Inventory Turnover Ratio GMED's Dividend Comparisons
GMED's Profitability Ratios GMED's Roi GMED's Asset Turnover Ratio GMED's Dividend Growth
GMED's Valuation Ratios GMED's Roe GMED's Financial Strength Ratios GMED's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Mannkind Corporation  12.39 $ 393.630  Millions$ 31.773  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Teladoc Health Inc   11.74 $ 2,489.480  Millions$ 212.023  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Caredx Inc   10.81 $ 458.089  Millions$ 42.359  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Kymera Therapeutics Inc   10.50 $ 105.000  Millions$ 10.000  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Irhythm Holdings Inc   10.32 $ 825.702  Millions$ 80.007  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Biodesix Inc   10.21 $ 102.939  Millions$ 10.081  Millions
Viemed Healthcare Inc   10.18 $ 301.606  Millions$ 29.637  Millions
Radnet Inc   10.11 $ 2,268.932  Millions$ 224.447  Millions
United Therapeutics Corporation  9.93 $ 3,154.500  Millions$ 317.550  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Lensar Inc   9.75 $ 60.264  Millions$ 6.184  Millions

Date modified: 2026-09-08T17:55:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.